{"id":"W2088947243","doi":"10.1016/j.ygyno.2014.05.016","title":"A phase II trial of sunitinib in women with metastatic or recurrent endometrial carcinoma: A study of the Princess Margaret, Chicago and California Consortia","year":2014,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; London Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Adverse effect; Clinical endpoint; Oncology; Phases of clinical research; Endometrial cancer; Toxicity; Progressive disease; Progression-free survival; Tyrosine-kinase inhibitor; Cancer; Surgery; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001042229,0.0001974801,0.001245075,0.0002692082,0.00006996666,0.000003628372,0.0001635448,0.0001037777,0.0003517998],"category_scores_gemma":[0.002916322,0.00009597638,0.00005648513,0.0009332874,0.0002990569,0.00002384803,0.000168112,0.000258762,0.000001048473],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002684512,"about_ca_system_score_gemma":0.0004542966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002203555,"about_ca_topic_score_gemma":0.00143018,"domain_scores_codex":[0.9974512,0.0008435994,0.0007403138,0.0003314992,0.0002974499,0.0003359405],"domain_scores_gemma":[0.9966353,0.002345403,0.0004893812,0.0002884657,0.0001044765,0.0001369427],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7030228,0.06232155,0.07621779,0.0002741387,0.000709874,0.0002043268,0.003258906,0.000004825762,0.0002680648,0.0001131928,0.00003783184,0.1535668],"study_design_scores_gemma":[0.5910735,0.3187144,0.08513407,0.00003564645,0.0005761108,0.00003609617,0.001998796,0.00001889875,0.0002181796,0.0001467102,0.001923677,0.0001240135],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953291,0.00008348872,0.000004332383,0.0003019696,0.0003155612,0.003219236,0.0000463728,0.00001137562,0.0006886098],"genre_scores_gemma":[0.9989864,0.00003195075,0.000147035,0.000151641,0.00006698753,0.0005587986,0.000005429949,0.00001057388,0.00004120059],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2563928,"threshold_uncertainty_score":0.3913803,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04853611210948144,"score_gpt":0.3468916180640979,"score_spread":0.2983555059546164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}